Literature DB >> 15893964

Determination of thymidine phosphorylase activity by a non-radiochemical assay using reversed-phase high-performance liquid chromatography.

André B P van Kuilenburg1, Lida Zoetekouw.   

Abstract

Thymidine phosphorylase (TP) catalyses the conversion of thymidine into thymine. A non-radiochemical assay procedure for TP was developed in which thymine was detected at 265 nm after separation with reversed-phase HPLC. A complete separation of thymidine and thymine was achieved in 6 min and the minimum amount of thymine that could be detected was 0.8 pmol. The assay was linear with reaction times, up to at least 4 h, and protein concentrations up to at least 65 microg/ml. Population analysis showed no differences in TP activity between man and women or with increasing age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893964     DOI: 10.1016/j.jchromb.2005.04.009

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Transition state analysis of thymidine hydrolysis by human thymidine phosphorylase.

Authors:  Phillip A Schwartz; Mathew J Vetticatt; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2010-09-29       Impact factor: 15.419

2.  Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome.

Authors:  Jaap A Bakker; Patrick Schlesser; Hubert J M Smeets; Baudouin Francois; Jörgen Bierau
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

3.  Mitochondrial neurogastrointestinal encephalomyopathy: Clinical and biochemical impact of allogeneic stem cell transplantation in a Greek patient with one novel TYMP mutation.

Authors:  A Paisiou; M Rogalidou; R Pons; E Ioannidou; K Dimakou; A Papadopoulou; F M Vaz; G Vessalas; S M I Goorden; J Roelofsen; A Zoetekouw; M M Nieman; E Dimitriou; M Moraitou; I Peristeri; H Michelakakis; A B P van Kuilenburg
Journal:  Mol Genet Metab Rep       Date:  2021-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.